CelLBxHealth PLC Presents Proof-of-Concept Study
Cellbxhealth PLC Announces Expert Consensus on CTCs; Update on Funding
ANGLE plc Announces Appointments: Interim CEO and Senior Board Advisor
Angle PLC Announces Strategy Update
Angle PLC Announces Presentation of Data on Glioblastoma
Angle PLC Announces Notice of Results
ANGLE Announces Collaboration with Myriad Genetics
Angle PLC Announces Parsortix Enables Study Of Cancer Progression
ANGLE PLC Announces Result of 2025 Annual General Meeting
Angle PLC - EACR 2025: Data Demonstrating DNA Dual Analysis
Angle PLC - EACR 2025: Innovation in AR Expression Profiling
ANGLE plc Announces Novel Discoveries Into the Biology of Cancer
Angle PLC Announces Posting of Annual Report and Notice of AGM
Angle PLC Announces Board Changes
Angle PLC Announces Preliminary Results
Angle PLC Announces Notice of Results
Angle PLC Announces Results of Eisai Phase 2 pilot study
Angle PLC Announces Issue of LTIP Options and Share Options
Angle PLC Announces Analysis of CTC-DNA and ctDNA using Illumina assay
Angle PLC Announces Parsortix Used in Research Paper from ETH Zurich